Literature DB >> 32833728

Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.

Guray Koc1, Zeki Odabasi1, Ersin Tan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32833728     DOI: 10.1097/CND.0000000000000316

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


× No keyword cloud information.
  9 in total

Review 1.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

2.  COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.

Authors:  Pietro Businaro; Gloria Vaghi; Enrico Marchioni; Luca Diamanti; Sebastiano Arceri; Paola Bini; Elena Colombo; Giuseppe Cosentino; Enrico Alfonsi; Alfredo Costa; Sabrina Ravaglia; Giulia Mallucci; Elena Ballante; Diego Franciotta; Matteo Gastaldi
Journal:  Muscle Nerve       Date:  2021-06-12       Impact factor: 3.852

3.  Reply to "Comprehensive work-up is warranted for patients with severe COVID-19 and muscle weakness including respiratory muscles".

Authors:  Lidia Cabañes-Martínez
Journal:  Clin Neurophysiol       Date:  2020-12-25       Impact factor: 3.708

4.  Perspectives of Neuro-COVID: Myasthenia.

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 5.  [Neuromuscular complications of SARS-CoV-2 infections-Part 1: peripheral nerves].

Authors:  Helmar C Lehmann; Benedikt Schoser; Gilbert Wunderlich; Peter Berlit; Gereon R Fink
Journal:  Nervenarzt       Date:  2021-03-26       Impact factor: 1.214

6.  Comprehensive work-up is warranted for patients with severe COVID-19 and muscle weakness including respiratory muscles.

Authors:  Josef Finsterer
Journal:  Clin Neurophysiol       Date:  2021-01-05       Impact factor: 3.708

Review 7.  Neurological Complications of COVID-19: Underlying Mechanisms and Management.

Authors:  Ghaydaa A Shehata; Kevin C Lord; Michaela C Grudzinski; Mohamed Elsayed; Ramy Abdelnaby; Hatem A Elshabrawy
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 8.  Clinical and Pathophysiologic Spectrum of Neuro-COVID.

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Mol Neurobiol       Date:  2021-04-08       Impact factor: 5.590

9.  Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy.

Authors:  Josef Finsterer
Journal:  Indian J Crit Care Med       Date:  2022-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.